首页 › 基金 › TCG Crossover Management, LLC › ABVX
TCG Crossover Management, LLC 对 ABVX 的持仓历史
ABIVAX SA · 医疗保健
TCG Crossover Management, LLC 在 Q3 2026 的 13F 申报中披露持有 ABVX(ABIVAX SA)3,663,038 股,市值约 US$362.7M,约占其申报组合的 10.25%,在其申报持仓中市值排名第 1 位。 TCG Crossover Management, LLC 最近 12 个申报季度中有 12 个季度披露了 ABVX 持仓,最早可追溯至 Q4 2023。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
TCG Crossover Management, LLC 对 ABVX 的持仓演变
TCG Crossover Management, LLC 于 Q4 2023 首次披露 ABVX 持仓:1,100,000 股(约 US$11.8M)。 该持仓在 Q4 2025 达到峰值 7,111,596 股,市值约 US$959.0M。 在 12 次申报中,TCG Crossover Management, LLC 2 次增持、3 次减持、6 次保持不变。 最近一期申报(Q3 2026)显示持股 3,663,038 股、市值约 US$362.7M,环比减持 -2,344,796 股。。 持仓曾出现大幅变动:Q2 2024 增持约 451% (随后一个季度股价下跌 13%)、Q3 2026 减持约 39% (随后一个季度股价下跌 12%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2023 | 1.10M | $11.77M | 新进 |
| Q1 2024 | 1.10M | $15.73M | 持有 |
| Q2 2024 | 6.06M | $80.07M | 增持 |
| Q3 2024 | 6.06M | $69.77M | 持有 |
| Q4 2024 | 6.06M | $44.33M | 持有 |
| Q1 2025 | 6.06M | $37.85M | 持有 |
| Q2 2025 | 6.06M | $46.33M | 持有 |
| Q3 2025 | 7.11M | $603.77M | 增持 |
| Q4 2025 | 7.11M | $959.03M | 持有 |
| Q1 2026 | 6.48M | $721.67M | 减持 |
| Q2 2026 | 6.01M | $800.60M | 减持 |
| Q3 2026 | 3.66M | $362.71M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ABVX 与 13F 数据
ABVX(ABIVAX SA)属于医疗保健行业。我们追踪的基金中还有 65 只申报持有 ABVX,申报仓位最大的包括:Helikon Investments Ltd (US$418.2M), Darwin Global Management, Ltd. (US$348.2M), Vestal Point Capital, LP (US$313.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ABVX 的基金
- Helikon Investments Ltd 4.22M 股 · $418.15M · Q3 2026
- Darwin Global Management, Ltd. 3.62M 股 · $348.22M · Q2 2026
- Vestal Point Capital, LP 2.35M 股 · $313.09M · Q2 2026
- Caligan Partners LP 1.56M 股 · $207.61M · Q2 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 1.65M 股 · $163.56M · Q3 2026
- RA CAPITAL MANAGEMENT, L.P. 1.13M 股 · $150.92M · Q2 2026
- Octagon Capital Advisors LP 993.00K 股 · $132.33M · Q2 2026
- Eversept Partners, LP 1.10M 股 · $108.99M · Q3 2026
- Cormorant Asset Management, LP 675.00K 股 · $89.95M · Q2 2026
- Logos Global Management LP 870.00K 股 · $86.15M · Q3 2026
- Boxer Capital Management, LLC 605.00K 股 · $80.62M · Q2 2026
- Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. 762.82K 股 · $75.53M · Q3 2026
更多关于 TCG Crossover Management, LLC
常见问题
How long has TCG Crossover Management, LLC held ABVX?
TCG Crossover Management, LLC has disclosed ABVX holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is TCG Crossover Management, LLC's current position in ABVX?
As of Q3 2026, TCG Crossover Management, LLC holds 3.66M shares of ABVX (ABIVAX SA), valued at $362.71M, representing 10.25% of its reported portfolio and ranking #1.
Has TCG Crossover Management, LLC been buying or selling ABVX?
In the latest 13F filing (Q3 2026), TCG Crossover Management, LLC reduced its position in ABVX. The position peaked in Q4 2025 at 7.11M shares.
Which other funds hold ABVX?
Other major institutional holders of ABVX include Helikon Investments Ltd, Darwin Global Management, Ltd., Vestal Point Capital, LP, among 65 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.